A Global Imatinib and Nilotinib Pregnancy Exposure Registry

Clinical trial NCT01289054 · COMPLETED

Trial details

NCT number: NCT01289054
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

All Indications for Glivec/Gleevec and Tasigna

Start date: 2011-01-01
Primary completion: 2015-03-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.